Search
× Search

Sinusitis (Rhinosinusitis or Sinus Infection)

Sinusitis (Rhinosinusitis or Sinus Infection)

Sinusitis is a term meaning inflammation of the sinuses. Patients with environmental allergies can be at greater risk for sinusitis as they already have some inflammation present in their nasal passages. This baseline inflammation occurs due to a reaction to the environmental allergens around them.

When sinusitis has a duration of 4 weeks or less it is considered "acute" sinusitis. Sometimes relapses of symptoms or inflammation can occur, deeming the condition "recurrent." When symptoms last longer than 12 weeks, the condition is defined as “chronic” sinusitis.

Acute sinusitis is often due to a viral infection and usually resolves in 7-10 days with supportive symptom management (saline sinus rinses, decongestants, nasal sprays) and the body’s natural ability to fight off illness. If symptoms last longer than 10 days, there is more concern for a bacterial infection and an antibiotic may be prescribed. Interestingly, many cases of bacterial sinusitis may resolve without the use of antibiotics and complications rarely develop.

If your medical provider prescribes antibiotics and symptoms aren’t improving, follow up is indicated. Other serious symptoms that would require follow up include: fevers >102 F that persist longer than 3-4 days, swelling or redness around the eyelids, vision changes, facial drooping or facial muscle weakness, confusion, headache, or inability to move the head/neck.

Chronic sinusitis can develop after an upper respiratory infection, an acute sinusitis that fails to resolve, or slowly over months/years until it becomes a problem. Signs in adults can include: facial pain/pressure, decreased sense of smell, discolored anterior or posterior nasal mucous, nasal stuffiness or congestion. A persistent cough may also occur (especially in children).

Treatment for chronic sinusitis generally includes nasal washes, nasal steroid and possibly oral steroids and/or an extended course of antibiotics. In some cases, sinus surgery may also be needed.

Because chronic sinusitis is a complex disorder of inflammation in the sinuses, it can take a while to treat. If the chronic sinusitis does not improve, evaluation by an Ear, Nose and Throat specialist may be needed to evaluate for nasal polyps, blocked drainage pathways or other problems that predispose to chronic sinusitis.

Recent News

SuperUser Account
/ Categories: News

AAFA’s 2024 Allergy Capitals™ report names most challenging cities for living with allergies, OKC – Fifth; Tulsa – Sixth in the top Ten

Washington D.C., March 14, 2024 — The Asthma and Allergy Foundation of America (AAFA) released its 2024 Allergy Capitals™ report detailing the most challenging cities in the United States for living with allergies. The full report can be found at allergycapitals.com.

This year, Wichita, Kansas takes the top spot due to its higher-than-average tree and grass pollen, higher-than-average medicine use, and limited access to allergy specialists. The top 10 Allergy Capitals™ for 2024 are: 1. Wichita, KS; 2. Virginia Beach, VA; 3. Greenville, SC; 4. Dallas, TX; 5. Oklahoma City, OK; 6. Tulsa, OK; 7. Richmond, VA 8. Des Moines, IA; 9. Raleigh, NC, and 10. Fayetteville, AR.

This year’s report again calls attention to the urgency of the climate crisis. Due to climate change, growing seasons start earlier and last longer than they did just 30 years ago. Some parts of the United States now experience pollen (tree, grass, or weed) year-round. Warmer temperatures also trap heat in urban areas, increase air pollution, and stimulate pollen production.

“Climate change fuels a perfect storm of conditions that make allergy season worse for people with pollen allergy,” said AAFA President and CEO Kenneth Mendez. “Longer growing seasons mean more exposure to pollen allergy triggers. Additionally, pollen counts tend to rise with warmer temperatures. Now, we see both more days of exposure to pollen and higher daily pollen counts leading to more intense, longer-lasting symptoms.”

AAFA’s 2024 Allergy Capitals™ report provides insight into factors impacting seasonal allergies. The report ranks the 100 most populous cities in the contiguous United States by their:

  • Tree, grass, and weed pollen scores
  • Over-the-counter allergy medicine use
  • Availability of board-certified allergists/immunologists 

Experts say a range of treatment options are available for people dealing with seasonal allergies this spring.

“Over-the-counter medicines can help manage symptoms,” said allergist Dr. Neeta Ogden, spokesperson for AAFA. “Working with a specialist can help you develop the best treatment plan.”

While the symptoms of pollen allergy can be managed, they are a significant health concern. Seasonal allergies can even lead to hospitalization if they trigger an asthma episode.

“Our pollen season continues to begin earlier each year,” said Dr. Claire Atkinson, a board-certified allergist with the Oklahoma Allergy & Asthma Clinic (OAAC). “We’ve already had several allergy alert days this year and we’ve not even made it to the official start of Spring. We want to encourage people who are suffering to see their medical provider and consider making an appointment with an allergist.”

A board-certified allergist can diagnose allergies, and determine the specific triggers that cause them, through simple tests. The allergists at OAAC evaluate and manage patients of all ages. The main clinic is on the Oklahoma Health Center campus. For patient convenience, satellite offices are in Edmond, Norman and Yukon.

Visit the OAAC website at www.oklahomaallergy.com to view the addresses for all Oklahoma Allergy and Asthma Clinic locations. To make an initial appointment or to request more information, please call (405) 235-0040 or visit the website.

For information on preventing and treating allergies and asthma, visit aafa.org.

The post AAFA’s 2024 Allergy Capitals™ report names most challenging cities for living with allergies, OKC – Fifth; Tulsa – Sixth in the top Ten appeared first on Oklahoma Allergy and Asthma Clinic.

Previous Article FDA Approves Takeda’s EOHILIA (budesonide oral suspension), the First and Only Oral Treatment in the U.S. for Eosinophilic Esophagitis (EoE)
Next Article Asthma Triggers
Print
20
Terms Of UsePrivacy StatementCopyright 2026 by Oklahoma Allergy and Asthma Clinic
Back To Top